title: Angiotensin-degrading serine peptidase: a new chymotrypsin-like activity in the venom of Bothrops jararaca partially blocked by the commercial antivenom.
abstract: Snakebite envenomation is considered a highly relevant public health hazard in South America, having an impact in terms of mortality and morbidity. In Brazil, Bothrops (sensu latu) poisoning is responsible for 90% of the snakebites and in patients treated at the Vital Brazil Hospital (Butantan Institute) this index reaches 97.5%. The objective of the present study was to analyze more specifically the ability of the antibothropic antivenom, produced by the Butantan Institute, São Paulo, Brazil, to neutralize metallo-and serine peptidases, known as the major toxins present in Bothrops jararaca venom. A set of Fret peptides (Free Ressonance Energy Transfer) was studied using the BjV (B. jararaca venom) and site-directed inhibitors PMSF, EDTA and 1,10-phenanthroline. Two substrates were reached to be used as specific tools for studies with metallo peptidases, Abz-FASSAQ-EDDnp, and the serine peptidases, Abz-RPPGFSPFRQ-EDDnp. In disagreement with the literature, the use of both substrates and the antibothropic serum showed a weak neutralization of the serine peptidases present in this venom and a strong neutralization of the metallo peptidases. In order to investigate possible mechanisms of action that have not yet been described for the serine peptidases from the BjV, the present study shows for the first time a new tyrosine-specific chymotrypsin-like and angiotensin-degrading serine peptidase activity, that was partially blocked by the antibothropic serum. In conclusion, the antivenom presented a good neutralization of metallo peptidases but not of serine peptidases, indicating that further studies about serine peptidases immunogenicity are necessary to improve the antibothropic serum.
authors.affiliation: Immunochemistry Laboratory, Butantan Institute, Av. Prof. Vital Brazil, 1500, CEP 05503-900, São Paulo, Brazil.
authors.forename: Alexandre Kazuo
authors.initials: AK
authors.lastname: Kuniyoshi
authors.forename: Marisa
authors.initials: M
authors.lastname: Rocha
authors.forename: Daniela
authors.initials: D
authors.lastname: Cajado Carvalho
authors.forename: Maria Aparecida
authors.initials: MA
authors.lastname: Juliano
authors.forename: Luiz
authors.initials: L
authors.lastname: Juliano Neto
authors.forename: Denise Vilarinho
authors.initials: DV
authors.lastname: Tambourgi
authors.forename: Fernanda Calheta Vieira
authors.initials: FC
authors.lastname: Portaro
mesh_terms: D000803:Angiotensin I / Q000737:chemistry; D000809:Angiotensins / Q000737:chemistry*; D000818:Animals; D000997:Antivenins / Q000737:chemistry / Q000494:pharmacology*; D017837:Bothrops; D002851:Chromatography, High Pressure Liquid; D002918:Chymotrypsin / Q000037:antagonists & inhibitors* / Q000737:chemistry; D003435:Crotalid Venoms / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000201:enzymology; D006868:Hydrolysis; D009500:Neutralization Tests
chemical_list: D000809:Angiotensins; D000997:Antivenins; D003435:Crotalid Venoms; D000803:Angiotensin I; D002918:Chymotrypsin